Works by Leis, Jose F.

Results: 55
    1

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    2

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    3
    4

    Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
    By:
    • Wang, Yucai;
    • Sinha, Sutapa;
    • Wellik, Linda E.;
    • Secreto, Charla R.;
    • Rech, Karen L.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Koehler, Amber B.;
    • Van Dyke, Daniel L.;
    • Leis, Jose F.;
    • Slager, Susan L.;
    • Dong, Haidong;
    • Kay, Neil E.;
    • He, Rong;
    • Ding, Wei
    Publication type:
    Article
    5

    Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

    Published in:
    2021
    By:
    • Hampel, Paul J.;
    • Parikh, Sameer A.;
    • Call, Timothy G.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Al-Kali, Aref;
    • Rabe, Kari G.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Hanson, Curtis A.;
    • Van Dyke, Daniel L.;
    • Shi, Min;
    • Ding, Wei
    Publication type:
    Letter
    6

    Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0302-9
    By:
    • Jain, Tania;
    • Kunze, Katie L.;
    • Mountjoy, Luke;
    • Partain, Daniel K.;
    • Kosiorek, Heidi;
    • Khera, Nandita;
    • Hogan, William J.;
    • Roy, Vivek;
    • Slack, James L.;
    • Noel, Pierre;
    • Fauble, Veena D. S.;
    • Leis, Jose F.;
    • Sproat, Lisa;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.;
    • Mesa, Ruben A.;
    • Palmer, Jeanne
    Publication type:
    Article
    7
    8
    9

    Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2383, doi. 10.1080/10428194.2020.1768384
    By:
    • Koehler, Amber B.;
    • Leung, Nelson;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Hampel, Paul J.;
    • Finnes, Heidi D.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    10
    11

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    12
    13
    14

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    15

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1630, doi. 10.1080/10428194.2016.1257795
    By:
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.;
    • Noseworthy, Peter A.;
    • Goede, Valentin;
    • Chaffee, Kari G.;
    • Bahlo, Jasmin;
    • Call, Timothy G.;
    • Schwager, Susan M.;
    • Ding, Wei;
    • Eichhorst, Barbara;
    • Fischer, Kirsten;
    • Leis, Jose F.;
    • Chanan-Khan, Asher Alban;
    • Hallek, Michael;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    16
    17
    18

    DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 5, p. 739, doi. 10.1002/ajh.26888
    By:
    • Huntington, Scott F.;
    • Schuster, Stephen J.;
    • Ding, Wei;
    • Koehler, Amber B.;
    • Brander, Danielle M.;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Tun, Han W.;
    • Moustafa, Muhamad Alhaj;
    • Iqbal, Madiha;
    • He, Wei;
    • Kearney, Albert S.;
    • McKinlay, Timothy P.;
    • Gui, Min;
    • Mato, Anthony R.
    Publication type:
    Article
    19

    Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. 90, doi. 10.1002/ajh.26388
    By:
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Johnson, Michael J.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Hayman, Suzanne R.;
    • Wang, Yucai;
    • Hampel, Paul J.;
    • Holets, Matthew A.;
    • Darby, Heather C.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Miao, Congrong;
    • Canniff, Jennifer;
    • Whitaker, Jennifer A.;
    • Levin, Myron J.;
    • Schmid, D. Scott
    Publication type:
    Article
    20

    The prognostic significance of del6q23 in chronic lymphocytic leukemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 6, p. E203, doi. 10.1002/ajh.26168
    By:
    • Audil, Hadiyah Y.;
    • Hampel, Paul J.;
    • Van Dyke, Daniel L.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Smoley, Stephanie A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Parikh, Sameer A.
    Publication type:
    Article
    21

    Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 8, p. 906, doi. 10.1002/ajh.25831
    By:
    • Kleinstern, Geffen;
    • O'Brien, Daniel R.;
    • Li, Xing;
    • Tian, Shulan;
    • Kabat, Brian F.;
    • Rabe, Kari G.;
    • Norman, Aaron D.;
    • Yan, Huihuang;
    • Vachon, Celine M.;
    • Boddicker, Nicholas J.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Bruins, Laura;
    • Bonolo de Campos, Cecilia;
    • Leis, Jose F.;
    • Shanafelt, Tait D.;
    • Ding, Wei;
    • Cerhan, James R.;
    • Kay, Neil E.;
    • Slager, Susan L.
    Publication type:
    Article
    22

    Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
    By:
    • Hampel, Paul J.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Muchtar, Eli;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Leis, Jose F.;
    • Witzig, Thomas E.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Rabe, Kari G.;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    23

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 338, doi. 10.1002/ajh.25385
    By:
    • Fang, Hong;
    • Reichard, Kaaren K.;
    • Rabe, Kari G.;
    • Hanson, Curtis A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Smoley, Stephanie A.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Van Dyke, Daniel L.;
    • Parikh, Sameer A.
    Publication type:
    Article
    24

    Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1362, doi. 10.1002/ajh.24915
    By:
    • Hampel, Paul J.;
    • Chaffee, Kari G.;
    • King, Rebecca L.;
    • Simonetto, Douglas;
    • Larson, Melissa C.;
    • Achenbach, Sara;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Schwager, Susan M.;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    25

    Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762
    By:
    • Larsen, Jeremy T.;
    • Shanafelt, Tait D.;
    • Leis, Jose F.;
    • LaPlant, Betsy;
    • Call, Tim;
    • Pettinger, Adam;
    • Hanson, Curtis;
    • Erlichman, Charles;
    • Habermann, Thomas Matthew;
    • Reeder, Craig;
    • Nikcevich, Daniel;
    • Bowen, Deborah;
    • Conte, Michael;
    • Boysen, Justin;
    • Secreto, Charla;
    • Lesnick, Connie;
    • Tschumper, Renee;
    • Jelinek, Diane;
    • Kay, Neil E.;
    • Ding, Wei
    Publication type:
    Article
    26

    A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
    By:
    • Rosenthal, Allison;
    • Dueck, Amylou C.;
    • Ansell, Stephen;
    • Gano, Katherine;
    • Conley, Christopher;
    • Nowakowski, Grzegorz S.;
    • Camoriano, John;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Keith Stewart, A.;
    • Inwards, David;
    • Dingli, David;
    • Kumar, Shaji;
    • Noel, Pierre;
    • Gertz, Morie;
    • Porrata, Luis;
    • Russell, Stephen;
    • Colgan, Joseph;
    • Fonseca, Rafael;
    • Habermann, Thomas M.
    Publication type:
    Article
    27
    28

    Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
    By:
    • Wiedmeier-Nutor, Julia E.;
    • Iqbal, Madiha;
    • Rosenthal, Allison C.;
    • Bezerra, Evandro D.;
    • Garcia-Robledo, Juan Esteban;
    • Bansal, Radhika;
    • Johnston, Patrick B.;
    • Hathcock, Matthew;
    • Larsen, Jeremy T.;
    • Leif Bergsagel, P.;
    • Wang, Yucai;
    • Reeder, Craig B.;
    • Leis, Jose F.;
    • Fonseca, Rafael;
    • Palmer, Jeanne M.;
    • Gysbers, Brianna J.;
    • Mwangi, Raphael;
    • Warsame, Rahma M.;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.
    Publication type:
    Article
    29

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    30
    31
    32
    33

    Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Shi, Min;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    34

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    35

    Clonal dynamics of Richter transformation in chronic lymphocytic leukemia.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3282
    By:
    • Wang, Hanyin;
    • Tian, Shulan;
    • Secreto, Charla R.;
    • Sinha, Sutapa;
    • Shi, Min;
    • Call, Timothy;
    • Wang, Yucai;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • He, Rong;
    • Leis, Jose F.;
    • VanDyke, Daniel L.;
    • Klee, Eric W.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Yan, Huihuang;
    • Ding, Wei
    Publication type:
    Article
    36

    Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950
    By:
    • Wang, Hanyin;
    • Tian, Shulan;
    • Zhao, Qing;
    • Blumenschein, Wendy;
    • Yearley, Jennifer H.;
    • Secreto, Charla R.;
    • Sinha, Sutapa;
    • Call, Timothy G.;
    • Wang, Yucai;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • He, Rong;
    • Leis, Jose F.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Kay, Neil E.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Yan, Huihuang;
    • Ding, Wei
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
    By:
    • Parikh, Sameer A.;
    • Achenbach, Sara J.;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Chanan‐Khan, Asher A.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Muchtar, Eli;
    • Fonder, Amie L.;
    • McCullough, Kristen B.;
    • Nedved, Adrienne N.;
    • Smith, Matthew D.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Finnes, Heidi D.;
    • Shanafelt, Tait D.
    Publication type:
    Article
    44
    45

    Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

    Published in:
    British Journal of Haematology, 2018, v. 183, n. 3, p. 421, doi. 10.1111/bjh.15545
    By:
    • Hampel, Paul J.;
    • Larson, Melissa C.;
    • Kabat, Brian;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Bowen, Deborah;
    • Boysen, Justin;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Muchtar, Eli;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Chaffee, Kari G.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    46
    47
    48
    49
    50

    Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non- Hodgkin lymphoma subtypes.

    Published in:
    British Journal of Haematology, 2012, v. 159, n. 5, p. 572, doi. 10.1111/bjh.12070
    By:
    • Slager, Susan L.;
    • Camp, Nicola J.;
    • Conde, Lucia;
    • Shanafelt, Tait D.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Kay, Neil E.;
    • Novak, Anne J.;
    • Call, Timothy G.;
    • Bracci, Paige M.;
    • Sille, Fenna M. C.;
    • Sanchez, Sylvia;
    • Akers, Nicholas K.;
    • Cunningham, Julie M.;
    • Serie, Daniel J.;
    • McDonnell, Shannon K.;
    • Leis, Jose F.;
    • Wang, Alice H.;
    • Weinberg, J. Brice;
    • Glenn, Martha
    Publication type:
    Article